Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

A0A6D2Y9A4 (A0A6D2Y9A4_PANTR) Pan troglodytes (Chimpanzee)

ELOB isoform 1 UniProtKBInterProInteractive Modelling

118 aa; Sequence (Fasta) ; 8 identical sequences: Homo sapiens: Q15370; Pongo abelii: A0A2J8S830; Pan troglodytes: K7BP33; Papio anubis: A0A096NL81; Macaca mulatta: I2CTS0; Macaca fascicularis: A0A2K5UJD0; Rhinopithecus bieti: A0A2K6KJ09; Piliocolobus tephrosceles: A0A8C9I8I0

Available Structures

151 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P40337; P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q15843; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
1-118
Assess
SOCS box elonginBC ternary complex Heteromer
O35718; P83940; Q15370;
1-118
Assess
HIV-1 Vif SOCS-box and Elongin BC solution structure Heteromer
P12504; Q15369; Q15370;
1-118
Assess
Crystal structure of VHL in complex with H313, a Helicon Polypeptide Heteromer
P40337; Q15369; Q15370;
1-108
WHL;
Assess
Structure of a HIF-1a-pVHL-ElonginB-ElonginC Complex Heteromer
P40337; Q15369; Q15370; Q16665;
1-106
Assess
Crystal structure of HIF-2alpha-pVHL-elongin B-elongin C Heteromer
P40337; Q15369; Q15370; Q99814;
1-106
Assess
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P61201; P62877; Q03071; Q13098; Q13617; Q15370; Q15843; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
1-106
ZN;
Assess
Structure of CRL2APPBP2 bound with the C-degron of MRPL28 (dimer) Heteromer
Q13617; Q15369; Q15370; Q92624;
1-106
ZN;
Assess
von Hippel-Lindau protein-ElonginB-ElonginC complex, bound to Hif1- alpha peptide Heteromer
P40337; Q15369; Q15370; Q16665;
1-105
GOL;
Assess
pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol Heteromer
P40337; Q15369; Q15370; Q16665;
1-105
SO4;F4K;GOL;
Assess
Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… Heteromer
P40337; Q15370; Q2KII4; Q99814;
1-105
GOL;
Assess
PROTAC6 mediated complex of VHL:EloB:EloC and Bcl-xL Heteromer
P40337; Q07817; Q15369; Q15370;
1-105
QL8; 17×EDO;GOL; 12×IOD;
Assess
Ternary complex of VHL/BRD4-BD1/Compound9 (4-(3,5-difluoropyridin-2-yl)-N-(11-(((S)-1-((2S,4R)-4-hy… Heteromer
O60885; P40337; Q15369; Q15370;
1-105
WEP;
Assess
CRYSTAL STRUCTURE OF SOCS-4 IN COMPLEX WITH ELONGIN-B AND ELONGIN-C AT 2.55A RESOLUTION Heteromer
Q15369; Q15370; Q8WXH5;
1-105
NA;EDO;CL;
Assess
pVHL-EloB-EloB-EloC complex_(2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidany… Heteromer
P40337; Q15369; Q15370;
1-105
ACT;UCK;
Assess
VHL recognizes hydroxyproline in RIPK1 Heteromer
P40337; Q13546; Q15369; Q15370;
1-105
Assess
Structure of CRL2APPBP2 bound with RxxGP degron (dimer) Heteromer
Q13617; Q15369; Q15370; Q92624;
2-106
ZN;
Assess
Ankyrin repeat and SOCS-box protein 9 (ASB9), ElonginB (ELOB), and ElonginC (ELOC) bound to its sub… Heteromer
P12277; Q15369; Q15370; Q96DX5;
2-106
Assess
Structure of CRL2APPBP2 bound with RxxGPAA degron (tetramer) Heteromer
P62877; Q13617; Q15369; Q15370; Q92624;
2-106
ZN;
Assess
Structure of CRL2APPBP2 bound with RxxGP degron (tetramer) Heteromer
P62877; Q13617; Q15369; Q15370; Q92624;
2-106
ZN;
Assess
Structure of CRL2APPBP2 bound with RxxGPAA degron (dimer) Heteromer
Q13617; Q15369; Q15370; Q92624;
2-106
ZN;
Assess
Ubiquitin ligation to neosubstrate by a cullin-RING E3 ligase & Cdc34: NEDD8-CUL2-RBX1-ELOB/C-VHL-M… Heteromer
O60885; P0CG48; P40337; P62877; Q13617; Q15369; Q15370; Q712K3;
1-105
ZN;SY8;759;
Assess
Structure of CRL2APPBP2 bound with the C-degron of MRPL28 (tetramer) Heteromer
P62877; Q13084; Q13617; Q15369; Q15370; Q92624;
2-106
ZN;
Assess
Crystal structure of compound 10 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
IOD;IFJ;
Assess
Ternary complex between VCB, BRD4-BD1 and PROTAC 48 Heteromer
O60885; P40337; Q15369; Q15370;
1-104
SO4;EDO;QIY;
Assess
Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA4 and pVHL:ElonginC:El… Heteromer
P40337; P51532; Q15369; Q15370;
1-104
FWZ;DMS;
Assess
Crystal structure of SOCS2:ElonginB:ElonginC in complex with compound MN551 Heteromer
O14508; Q15369; Q15370;
1-104
JIH;
Assess
pVHL:EloB:EloC in complex with modified HIF-1a CODD peptide containing (3R,4S)-3-fluoro-4-hydroxypr… Heteromer
P40337; Q15369; Q15370; Q16665;
1-104
Assess
co-crystal structure of SOCS2:ElonginB:ElonginC in complex with compound 13 Heteromer
O14508; Q15369; Q15370;
1-104
EDO;JH9;
Assess
Crystal structure of SOCS2:ElonginB:ElonginC in complex with compound 9 Heteromer
O14508; Q15369; Q15370;
1-104
JHR;PO4;
Assess
Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… Heteromer
P40337; Q15369; Q15370; Q99814;
1-104
FMT;
Assess
Crystal structure of compound 6 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
IFF;
Assess
Crystal structure of the VCB complex with compound 1. Heteromer
P40337; Q15369; Q15370;
1-104
WBN;CL;
Assess
Crystal structure of a hydroxylated HIF-1 alpha peptide bound to the pVHL/elongin-C/elongin-B compl… Heteromer
P40337; Q15369; Q15370; Q16665;
1-104
SO4;
Assess
pVHL-ELOB-ELOC complex_(2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)ben… Heteromer
P40337; Q15369; Q15370;
1-104
TG0;
Assess
Crystal structure of SOCS2:ElonginB:ElonginC in complex with compound 13 Heteromer
O14508; Q15369; Q15370;
1-104
JH9;
Assess
VCB in complex with compound 30 Heteromer
P40337; Q15369; Q15370;
1-104
QE0;
Assess
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #2) Heteromer
P40337; P61964; Q15369; Q15370;
1-104
SCN;Q3X;EDO;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-4-hydroxy-1-((S)-2-(2-hydroxyacetamido)-3,3-dimethylbutanoyl… Heteromer
P40337; Q15369; Q15370;
1-104
9BT;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-y… Heteromer
P40337; Q15369; Q15370;
1-104
3JU;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclobutanecarboxamido)-3,3-dimethylbutanoyl)-4-hy… Heteromer
P40337; Q15369; Q15370;
1-104
9BH;
Assess
VCB in complex with compound 32 Heteromer
P40337; Q15369; Q15370;
1-104
QF7;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-h… Heteromer
P40337; Q15369; Q15370;
1-104
9BW;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-3,3-dimethyl-2-(oxetane-3-carboxamido)butanoyl)-4-hyd… Heteromer
P40337; Q15369; Q15370;
1-104
9B8;
Assess
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with Aryl linker Heteromer
P40337; P61964; Q15369; Q15370;
1-104
10×SCN;Q43;EDO;K;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-fluorocyclopropanecarboxamido)-3,3-dimethylbutan… Heteromer
P40337; Q15369; Q15370;
1-104
4YY;
Assess
Crystal Structure of compound 3 in complex with KRAS G12V C118S GDP and pVHL:ElonginC:ElonginB Heteromer
P01116; P40337; Q15369; Q15370;
1-104
GDP;X4R;MG;
Assess
Crystal structure of SOCS2:ElonginB:ElonginC in complex with compound 12 Heteromer
O14508; Q15369; Q15370;
1-104
JI0;
Assess
Crystal structure of PROTAC 1 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
FX8; 11×EDO;FMT;
Assess
Crystal structure of PROTAC 5 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
IEI;
Assess
Crystal Structure of ligand ACBi1 in complex with bromodomain of human Smarca2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
EDO;NA;PEG;87A;
Assess
VCB in complex with compound 27 Heteromer
P40337; Q15369; Q15370;
1-104
QF3;
Assess
Crystal structure of pVHL:ElonginC:ElonginB complex bound to PROTAC JW48 Heteromer
P40337; Q15369; Q15370;
1-104
SYF;
Assess
pVHL:EloB:EloC in complex with modified VH032 containing (3S,4S)-3-fluoro-4-hydroxyproline (ligand … Heteromer
P40337; Q15369; Q15370;
1-104
EXE;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetamidocyclopropanecarboxamido)-3,3-dimethylbu… Heteromer
P40337; Q15369; Q15370;
1-104
9BK;
Assess
von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-N-methyl-1-[2-(3-methy… Heteromer
P40337; Q15369; Q15370;
1-104
QD0;
Assess
Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
EDO;FWZ;EPE;
Assess
Crystal Structure of compound 4 in complex with KRAS G12V C118S GDP and pVHL:ElonginC:ElonginB Heteromer
P01116; P40337; Q15369; Q15370;
1-104
X53;GDP;MG;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-N-((S)-1-(5-Fluoro-2-methoxy-4-(4-methylthiazol-5-yl)phenyl)… Heteromer
P40337; Q15369; Q15370;
1-104
VH3;
Assess
pVHL:EloB:EloC in complex with VH298 Heteromer
P40337; Q15369; Q15370;
1-104
6Z3;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-Acetamidopropanethioyl)-4-hydroxy-N-(4-(4-methylthi… Heteromer
P40337; Q15369; Q15370;
1-104
DV5;
Assess
Crystal structure of EloBC-VHL-CDO1 complex bound to compound 8 molecular glue Heteromer
P40337; Q15369; Q15370; Q16878;
1-104
A1ACI;CIT;FE2;
Assess
Crystal Structure of Ankyrin Repeat and Socs Box-Containing Protein 9 (Asb9) in Complex with Elongi… Heteromer
Q15369; Q15370; Q96DX5;
2-105
EDO;PEG;CL;
Assess
Crystal structure of SOCS2:ElonginB:ElonginC in complex with compound 11 Heteromer
O14508; Q15369; Q15370;
1-104
JI9;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbu… Heteromer
P40337; Q15369; Q15370;
1-104
VYQ;
Assess
pVHL54-213-EloB-EloC complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)- 4-hydroxy-1-(2-(3-methylisox… Heteromer
P40337; Q15369; Q15370;
1-104
TR0;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetylcyclopropanecarboxamido)-3,3-dimethylbutan… Heteromer
P40337; Q15369; Q15370;
1-104
9BN;
Assess
Co-crystal structure of Compound 11 in complex with the bromodomain of human SMARCA2 and pVHL:Elong… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
GOL;FWZ;
Assess
pVHL:EloB:EloC in complex with modified VH032 containing (3R,4S)-3-fluoro-4-hydroxyproline (ligand … Heteromer
P40337; Q15369; Q15370;
1-104
EXH;
Assess
The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB Heteromer
O60885; P40337; Q15369; Q15370;
1-104
759;
Assess
Ternary complex between VCB, BRD4-BD2 and PROTAC 51 Heteromer
O60885; P40337; Q15369; Q15370;
1-104
QLX;
Assess
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… Heteromer
P40337; Q15369; Q15370;
1-104
DV8;
Assess
VCB in complex with compound 23 Heteromer
P40337; Q15369; Q15370;
1-104
QFR;
Assess
Crystal structure of SOCS2:Elongin C:Elongin B in complex with growth hormone receptor peptide Heteromer
O14508; Q15369; Q15370;
1-104
CO;
Assess
SelDeg51 in complex with FKBP51FK1 domain and pVHL:EloB:EloC Heteromer
P40337; Q13451; Q15369; Q15370;
1-104
XZW;
Assess
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with C3 linker Heteromer
P40337; P61964; Q15369; Q15370;
1-104
Q3R;
Assess
VCB in complex with compound 21 Heteromer
P40337; Q15369; Q15370;
1-104
QFF;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbu… Heteromer
P40337; Q15369; Q15370;
1-104
VFO;
Assess
Ankyrin repeat and SOCS-box protein 9 (ASB9) in complex with ElonginB and ElonginC Heteromer
Q15369; Q15370; Q96DX5;
2-105
EDO;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamidopropanoyl)-4-hydroxy-N-(4-(4-methylthiazol… Heteromer
P40337; Q15369; Q15370;
1-104
9B5;
Assess
Crystal structure of EloBC-VHL-CDO1 complex bound to compound 4 molecular glue Heteromer
P40337; Q15369; Q15370; Q16878;
1-104
3JF;CIT;FE2;
Assess
Ternary complex between VCB, BRD4-BD2 and PROTAC 48 Heteromer
O60885; P40337; Q15369; Q15370;
1-104
QIY;
Assess
Ternary complex between VCB, BRD4-BD1 and PROTAC 49 Heteromer
O60885; P40337; Q15369; Q15370;
1-104
SO4;QIK;
Assess
Structure of VHL-EloB-EloC-Cul2 Heteromer
P40337; Q13617; Q15369; Q15370;
1-104
Assess
Crystal structure of macrocyclic PROTAC 1 in complex with the second bromodomain of human Brd4 and … Heteromer
O60885; P40337; Q15369; Q15370;
1-104
LFE;
Assess
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
1-104
Assess
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P40337; P61201; P62877; Q03071; Q13098; Q13617; Q15370; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
1-104
ZN;
Assess
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
1-104
ZN;
Assess
Structure of cGAS in complex with SPSB3-ELOBC Heteromer
Q15369; Q15370; Q6PJ21; Q8N884;
1-104
ZN;
Assess
cGAS-Nucleosome in complex with SPSB3-ELOBC (composite structure) Heteromer
P62805; Q15369; Q15370; Q6PJ21; Q71DI3; Q8N884; Q93079; Q96KK5; Q99877; Q99878;
1-104
ZN;
Assess
Open non-crosslinked structure Brd4BD2-MZ1-(NEDD8)-CRL2VHL Heteromer
L7N190; O60885; P40337; Q13617; Q15370;
1-104
759;ZN;
Assess
(NEDD8)-CRL2VHL-MZ1-Brd4BD2-Ub(G76S, K48C)-UBE2R1(C93K, S138C, C191S, C223S)-Ub Heteromer
L7N190; O60885; P0CG48; P40337; P49427; Q13617; Q15370; Q15843;
1-104
759;ZN;
Assess
Crystal structure of Protac MS33 in complex with the WD repeat-containing protein 5 and pVHL:Elongi… Heteromer
P40337; P61964; Q15369; Q15370;
1-103
SCN;EDO;VKA;GOL;NA;
Assess
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #1) Heteromer
P40337; P61964; Q15369; Q15370;
1-103
15×SCN; 13×EDO;P6G;Q3X;
Assess
CRYSTAL STRUCTURE OF SOCS-2 IN COMPLEX WITH ELONGIN-B AND ELONGIN-C AT 1.9A RESOLUTION Heteromer
O14508; Q15369; Q15370;
2-104
SO4;NI;
Assess
pVHL:EloB:EloC in complex with methyl 4H-furo[3,2-b]pyrrole-5-carboxylate Heteromer
P40337; Q15369; Q15370;
1-103
ACT;F4E;
Assess
Crystal structure of SOCS2:Elongin C:Elongin B in complex with growth hormone receptor peptide Heteromer
O14508; Q15369; Q15370;
1-103
CO;
Assess
VCB in complex with compound 26 Heteromer
P40337; Q15369; Q15370;
1-103
QE9;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamido-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-m… Heteromer
P40337; Q15369; Q15370;
1-103
3JF;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3-phenylpropanamido)-3,3-dimethylb… Heteromer
P40337; Q15369; Q15370;
1-103
3JO;
Assess
Crystal structure of Protac MS67 in complex with the WD repeat-containing protein 5 and pVHL:Elongi… Heteromer
P40337; P61964; Q15369; Q15370;
1-103
GOL;X6M;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3,3-dimethylbutanamido)-3,3-dimeth… Heteromer
P40337; Q15369; Q15370;
1-103
3JJ;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methyloxazol-5-yl… Heteromer
P40337; Q15369; Q15370;
1-103
3JK;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-4-methylpentanamido)-3,3-dimethylb… Heteromer
P40337; Q15369; Q15370;
1-103
3JH;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(oxazol-5-yl)benzyl)… Heteromer
P40337; Q15369; Q15370;
1-103
3JG;
Assess
von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-1-ethanoyl-N-[[4-(1,3-… Heteromer
P40337; Q15369; Q15370;
1-103
X6C;ACT;
Assess
Crystal Structure of ligand ACBI3 in complex with KRAS G12D C118S GDP and pVHL:ElonginC:ElonginB co… Heteromer
P01116; P40337; Q15369; Q15370;
1-103
WYL;GDP;MG;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carbonyl)-4-hydro… Heteromer
P40337; Q15369; Q15370;
1-103
3JS;
Assess
pVHL:EloB:EloC complex, in complex with capped Hydroxyproline Heteromer
P40337; Q15369; Q15370;
1-103
ACT;V6F;
Assess
Quaternary Complex of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC Homer Heteromer
P40337; P61964; Q15369; Q15370;
1-103
8KH;
Assess
pVHL:EloB:EloC in complex with 6-chlorothiochroman-4-one Heteromer
P40337; Q15369; Q15370;
1-103
F7B;IPA;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(thiazol-5-yl)benzyl… Heteromer
P40337; Q15369; Q15370;
1-103
3JT;
Assess
Crystal structure of SOCS2:Elongin C:Elongin B in complex with erythropoietin receptor peptide Heteromer
O14508; Q15369; Q15370;
1-103
PEG;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(3-methyl-4-(thiazol-5-… Heteromer
P40337; Q15369; Q15370;
1-103
3JV;
Assess
pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol Heteromer
P40337; Q15369; Q15370;
1-103
Assess
pVHL54-213-EloB-EloC complex _ methyl 4-(((2S,4R)-4-hydroxy-1-(2-(3- methylisoxazol-5-yl)acetyl)pyr… Heteromer
P40337; Q15369; Q15370;
1-103
ZTD;
Assess
pVHL54-213-EloB-EloC complex_apo Heteromer
P40337; Q15369; Q15370;
1-103
Assess
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… Heteromer
P40337; Q15369; Q15370;
1-103
DV2;
Assess
Structure of SOCS2:Elongin C:Elongin B from DMSO-treated crystals Heteromer
O14508; Q15369; Q15370;
2-104
Assess
BRG1 bromodomain in complex with VBC via compound 17 Heteromer
P40337; P51532; Q15369; Q15370;
1-103
PO4;GOL;VLH;
Assess
VHL/Elongin B/Elongin C complex with compound 155 Heteromer
P40337; Q15369; Q15370;
1-103
VL6;
Assess
Crystal structure of SOCS2/ElonginB/ElonginC bound to a non-canonical peptide that enhances phospho… Heteromer
O14508; Q15369; Q15370;
2-104
SO4;
Assess
Co-crystal structure of Compound 1 in complex with the bromodomain of human SMARCA4 and pVHL:Elongi… Heteromer
P40337; P51532; Q15369; Q15370;
1-103
NA;YHB;PEG;
Assess
PROTAC-mediated complex of KRAS with VHL/Elongin-B/Elongin-C/Cullin-2/Rbx1 Heteromer
P01116; P40337; P62877; Q13617; Q15369; Q15370;
2-104
ZN;GDP;WYL;
Assess
pVHL54-213-EloB-EloC complex_(2S,4R)-4-hydroxy-1-(2-(3-methylisoxazol- 5-yl)acetyl)-N-(4-nitrobenzy… Heteromer
P40337; Q15369; Q15370;
1-102
GOL;ZUN;
Assess
CRYSTAL STRUCTURE OF AT7 IN COMPLEX WITH THE SECOND BROMODOMAIN OF HUMAN BRD4 AND PVHL:ELONGINC:ELO… Heteromer
O60885; P40337; Q15369; Q15370;
1-102
IZR;
Assess
DNA-encoded library (DEL)-enabled discovery of proximity inducing small molecules Heteromer
O60885; P40337; Q15369; Q15370;
1-102
X5K;
Assess
Crystal Structure of the HIV Vif BC-box in Complex with Human ElonginB and ElonginC Heteromer
P12504; Q15369; Q15370;
1-100
Assess
Crystal Structure of SOCS1 in complex with ElonginB and ElonginC Heteromer
C0LEJ4; Q00560; Q15369; Q15370;
1-100
Assess
Structure of KLHDC2-EloB/C tetrameric assembly Heteromer
Q15369; Q15370; Q9Y2U9;
1-99
Assess
pVHL54-213-EloB-EloC complex (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL… Heteromer
P40337; Q15369; Q15370;
1-99
L8B;
Assess
Ubiquitin ligation to substrate by a cullin-RING E3 ligase & Cdc34: NEDD8-CUL2-RBX1-ELOB/C-FEM1C wi… Heteromer
P0CG48; P62877; Q13617; Q15369; Q15370; Q712K3; Q96JP0; Q9H173;
1-99
U9O;ZN;
Assess
THE VHL-ELONGINC-ELONGINB STRUCTURE Heteromer
P40337; Q15369; Q15370;
1-98
Assess
Crystal structure of SIVrcm Vif-CBFbeta-ELOB-ELOC complex Heteromer
E1ANT9; Q13951; Q15369; Q15370;
1-98
ZN;GOL;
Assess
Crystal structure of the Vif-CBFbeta-CUL5-ElOB-ElOC pentameric complex Heteromer
P12504; Q13951; Q15369; Q15370; Q93034;
1-98
ZN;
Assess
KLHDC2 in complex with EloB and EloC Heteromer
Q15369; Q15370; Q9Y2U9;
1-98
Assess
Crystal structure of the Cul2-Rbx1-EloBC-VHL ubiquitin ligase complex Heteromer
P40337; P62877; Q13617; Q15369; Q15370;
1-97
ZN;
Assess
H. sapiens replisome-CUL2/LRR1 complex Heteromer
O75419; O75717; P25205; P33991; P33992; P33993; P49736; P56282; P62877; Q07864; Q13617; Q14566; Q14691; Q15369; Q15370; Q96L50; Q9BRT9; Q9BRX5; Q9BVW5; Q9HAW4; Q9UNS1; Q9Y248;
1-97
ZN;MG;ANP;SO4;
Assess
K48-linked ubiquitin chain formation with a cullin-RING E3 ligase and Cdc34: NEDD8-CUL2-RBX1-ELOB/C… Heteromer
P0CG48; P62877; Q13617; Q15369; Q15370; Q712K3; Q96JP0; Q9H173;
1-97
SY8;ZN;
Assess
An asymmetry dimer of the Cul2-Rbx1-EloBC-FEM1B ubiquitin ligase complexed with BEX2 Heteromer
P62877; Q13617; Q15369; Q15370; Q9UK73;
1-97
ZN;
Assess
Cryo-EM structure of neddylated Cul2-Rbx1-EloBC-FEM1B complexed with FNIP1-FLCN Heteromer
Q13617; Q15369; Q15370; Q8TF40; Q9UK73;
1-97
ZN;
Assess
Protomer 1 and 2 of the asymmetry trimer of the Cul2-Rbx1-EloBC-FEM1B ubiquitin ligase complex Heteromer
P62877; Q13617; Q15369; Q15370; Q9UK73;
1-97
ZN;
Assess
Maedi visna virus Vif in complex with CypA and E3 ubiquitin ligase Heteromer
P62937; P69717; Q15369; Q15370;
1-96
ZN;
Assess
Dimeric form of HIV-1 Vif in complex with human CBF-beta, ELOB, ELOC, and CUL5 Heteromer
P12504; Q13951; Q15369; Q15370; Q93034;
1-96
ZN;
Assess
Human APOBEC3H bound to HIV-1 Vif in complex with CBF-beta, ELOB, ELOC, and CUL5 Heteromer
P12504; Q13951; Q15369; Q15370; Q6NTF7; Q93034;
1-96
ZN;
Assess
Cryo-EM structure of human APOBEC3G/HIV-1 Vif/CBFbeta/ELOB/ELOC dimeric complex in State 2 Heteromer
P69723; Q13951; Q15369; Q15370; Q9HC16;
2-96
ZN;
Assess
Cryo-EM structure of human APOBEC3G/HIV-1 Vif/CBFbeta/ELOB/ELOC monomeric complex Heteromer
P69723; Q13951; Q15369; Q15370; Q9HC16;
2-96
ZN;
Assess
Cryo-EM structure of human APOBEC3G/HIV-1 Vif/CBFbeta/ELOB/ELOC dimeric complex in State 1 Heteromer
P69723; Q13951; Q15369; Q15370; Q9HC16;
2-96
ZN;
Assess
Structure of the mammalian Pol II-Elongin complex, lacking the ELOA latch (composite structure, str… Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P60899; Q14241; Q15369; Q15370;
1-88
MG;ZN;
Assess
Structure of the mammalian Pol II-SPT6-Elongin complex, lacking ELOA latch (composite structure, st… Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P60899; Q14241; Q15369; Q15370; Q7KZ85;
1-88
MG;ZN;
Assess
Structure of the mammalian Pol II-SPT6-Elongin complex, Structure 1 Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P60899; Q14241; Q15369; Q15370; Q7KZ85;
1-88
MG;ZN;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4b95.1.Amonomer0.751-104
100.00
Assess